{
    "2020-09-04": [
        [
            {
                "time": "2023-10-17",
                "original_text": "Lilly (LLY) Gets FDA Approval for Higher Doses of Trulicity",
                "features": {
                    "keywords": [
                        "Lilly",
                        "FDA Approval",
                        "Trulicity",
                        "Higher Doses"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "I-Mab",
                        "Cancer Drug",
                        "Savara",
                        "Cystic Fibrosis",
                        "Pulls The Plug"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}